Irena Royzman Publishes in Nature Biotechnology on the Impact of the Supreme Court’s New Approach to Patent Eligibility on Biotech Inventions

September 15, 2015

Irena Royzman, Co-Chair of the firm’s Biotechnology Practice, published an article in the September 2015 issue of Nature Biotechnology describing how the Supreme Court’s new approach to what is patentable not only puts the US biotech industry at a competitive disadvantage but also misapprehends the nature of innovation in biotech.

To read Ms. Royzman’s article, “Biotechnology Patents Under Fire,” please click here.